Abbott Laboratories discovers, develops, manufactures and sells of a range of health care products. Co.'s reportable segments are: established pharmaceutical products, which include a range of generic pharmaceuticals; diagnostic products, which include a range of diagnostic systems and tests; nutritional products, which include a range of pediatric and adult nutritional products; and Cardiovascular and neuromodulation products, which include a range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. We show 39 historical shares outstanding datapoints in our coverage of ABT's shares outstanding history.
Understanding the changing numbers of ABT shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABT versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABT by allowing them to research ABT shares outstanding history
as well as any other stock in our coverage universe. |
Video: Shares Outstanding Importance
